Knowledge Bank
Recent Articles:
"TABS Group Sets sights on Global Market”
Chain Drug Review - 07/14/08
"Kurt Jetta Promotional Theory”
Press Release - 07/08/08
"People in the Spotlight - Kurt Jetta”
MMR - 06/23/08
“Venerable Brands Maintain Pace in Tough Times”
Chain Drug Review - 03/17/08
“Michael Surmeian Joins the TABS Group”
PR - 02/29/08
“'Women's Supplement Usage Declines”
Chain Drug Review - 02/18/08
“'Drug Store New Industry Summit - Joyner & Jetta”
Drug Store News - 02/11/08
“'TABS Group Releases intriguing Voting Trends”
PR - 01/15/08
“'Joyner to Speak at NACDS Regional Conference 02/03/08”
PR - 01/07/08
“'Variety Brings Vibrance to Mix - Personal Soaps”
MMR Article - 09/10/07
“'Joyner Presentation to AHBAI”
AHBAI Conference - 08/27/07
“'Consumers Are Trading Up”
MMR Article - 08/13/07
“'Joyner to speak at AHBAI conference in Las Vegas”
Drug Store News - 08/06/07
“'Evolution of Category Management”
Consumer Goods Technology - 06/07/07
“'Category Mgmt Evolves into Total Store Analytics”
Chain Drugstore Daily - 04/22/07
“'Hair Care 2007”
MMR - 02/26/07
“'The Evolution of Category Management”
Candy & Snack Business - Jan/Feb 2007
“'True Innovation' Keeps Category Moving Ahead”
Chain Drug Review - 02/05/07
“Joyner Offers New Ideas on Driving Sales” MMR Article - 01/08/07
“TABS Group Launches Total Store Analytics ”
December 06 Press Release
“The J Joyner Group Launches Sales Agency”
November 06 Press Release
Aisle Mastery: “What You Don’t Know Can Hurt You”
June 2006 ECRM Focus
“A Mega-Category with Unique Traits”
February 2006 Chain Drug Review
“TABS Pegs Vitamins at $7.5B Well Below Industry Estimatess”
December 2005 Press Release
“Using FORCE for More Effective Selling Presentations”
October 2005 ECRM Focus
“Tier 2 Brands Bring Innovation, Excitement, and Growth”
August 2005 ECRM Focus
“The Value of ‘Value Brands’”
July 2004 Expose
“Retailer-Relevant Analysis”
April 2004 Expose
“Harnessing the Power of High/Low Promotions”
October 27, 2003 Chain Drug Review
“Foot Care is a Microcosm of overall H&BA Market”
August 19, 2002 Chain Drug Review
